N4-(3-Chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4,6-quinazolinediamine
99%
- Product Code: 54189
CAS:
314771-76-1
| Molecular Weight: | 374.8 g./mol | Molecular Formula: | C₁₈H₁₆ClFN₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of targeted cancer therapies. It plays a significant role in the development of kinase inhibitors, which are designed to interfere with specific signaling pathways involved in tumor growth and proliferation. Its structure is particularly effective in binding to certain tyrosine kinases, making it valuable in the creation of drugs aimed at treating cancers such as non-small cell lung cancer and breast cancer. Additionally, its unique chemical properties contribute to the enhancement of drug efficacy and selectivity, reducing off-target effects and improving patient outcomes.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Yellow Solid |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | $14.70 |
+
-
|
| 1.000 | 10-20 days | $29.40 |
+
-
|
| 5.000 | 10-20 days | $110.71 |
+
-
|
| 10.000 | 10-20 days | $203.12 |
+
-
|
| 25.000 | 10-20 days | $457.55 |
+
-
|
N4-(3-Chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4,6-quinazolinediamine
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of targeted cancer therapies. It plays a significant role in the development of kinase inhibitors, which are designed to interfere with specific signaling pathways involved in tumor growth and proliferation. Its structure is particularly effective in binding to certain tyrosine kinases, making it valuable in the creation of drugs aimed at treating cancers such as non-small cell lung cancer and breast cancer. Additionally, its unique chemical properties contribute to the enhancement of drug efficacy and selectivity, reducing off-target effects and improving patient outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :